Surgical reconstruction of muscle tissue lost by trauma or tumor ablation is limited by the lack of availability of functional native tissue substitution. Moreover, so far most inherited or acquired muscle diseases are lacking sufficient treatment, because only few alternatives exist to provide functional restoration of lost muscle tissues. Engineering those tissues and transplantation into sites of dysfunction may be an alternative approach and may allow replacement of such damaged or failing skeletal muscle tissues. Techniques attempting reconstruction of some human tissues and organs (tissue engineering) have been introduced into clinical practice recently. One major problem that previous transplantation studies were facing is the ability of detection of transplanted cells after integration. Using the Y chromosome in situ hybridization technique in a syngeneic rat model allows transplantation of cell constructs orthotopically, without manipulation of the cells, with no rejection or immunosuppression being implied, but providing a nondilutable genetic marker to identify transplanted cells. The purpose of our study was to create functional skeletal muscle tissue in vivo using the transplantation of primary myoblasts precultivated within a three-dimensional (3D) fibrin matrix and to determine the fate of the transplanted cells using the Y chromosome detection technique. 3D myoblast cultures were established derived from male donor rats and after 7 days of cultivation we performed an orthotopic transplantation of 3D cell constructs into a created muscle defect within the gracilis muscle of syngeneic female rats. Anti-desmin immunostaining and Y chromosome in situ hybridization indicated the survival and integration of transplanted male myoblasts into the female recipient animal, thus demonstrating the feasibility of this approach in tissue engineering and the research of cell transplantation in general.
INTRODUCTION
myoblasts or in vitro expansion only followed by in vivo myogenic differentiation after autologous transplanta-The creation of skeletal muscle tissue in vitro holds tion. Furthermore, the integration and identification of promise for the treatment of a variety of inherited and transplanted cells into remaining skeletal muscle after acquired human diseases (8, 10, 18) . Therapeutic treattransfer of autologous muscle tissue is arguable and ments for skeletal muscle disorders and loss of skeletal needs to be evaluated (28). muscle tissue require either the implantation of con-In previous studies we used a novel three-dimenstructs of differentiated muscle tissue or the injection of sional (3D) coculture model, where primary myoblasts muscle precursor cells into sites of dysfunction or tissue from male rats were expanded over four passages and deficiency for subsequent formation of new muscle tiscocultivated with slice cultures of spinal cords from synsue (8). However, this technique is limited by the large geneic male rats within a fibrin gel matrix. In these numbers of cells required and sites that must be injected studies differentiation of cocultivated myoblasts to spon-(22). In vitro differentiation and maturation of satellite taneously contracting myofibers expressing specific cells harvested from adult skeletal muscle could be an myogenic markers was observed, indicating a high dealternative source for treating muscular disorders (1). To gree of myogenic differentiation. Because for later cliniachieve this goal it is necessary to investigate novel apcal application cocultivation with spinal cord tissue proaches for culturing functional, differentiated skeletal explants is not practical, we have used a different, clinimuscle tissue by either in vitro differentiation of primary cally more promising approach in this study. Primary rat 46 BEIER ET AL. myoblasts were harvested from newborn rats, expanded female recipient rats (20, 21) , while Zweifel et al. used the same technique to detect invading male host cells over four passages, and cultivated in a 3D fibrin matrix. In accordance with our previous studies, there was no into transplanted female rat hearts (29). To our knowledge, no investigations using this transplantation model further myogenic differentiation, like fusion to myofibers, being expected in vitro, while the integration and have been published focusing on a soft tissue reconstruction approach. possible differentiation was questioned to be induced by the host's organism in vivo.
The purpose of this study was to establish an adequate animal model in which orthotopic transplantation To evaluate the in vivo differentiation potential of our 3D myoblast culture, as well as the integration of experiments of tissue-engineered cell constructs can be conducted. Furthermore, the aim was to identify and char-transplanted cells into the host tissue, an adequate transplantation model for the in vitro created skeletal muscle acterize transplanted cells of 3D myoblast constructs and their integration in the skeletal muscle tissue of a synge-constructs was necessary. There are several different approaches to conduct transplantation experiments: the clos-neic host animal. The rat probe was used in the current study to determine the fate of primary cultivated myoblasts est way of emulating the autologous transplantation used in tissue engineering would be a syngeneic model, where after transplantation. We expanded myoblasts from newborn rats over four passages. After confirming the male no rejection of transplanted cells is expected to occur. The major problem of syngeneic transplantations is the chromosomal sex of the donor animals by Y chromosomespecific PCR, 3D myoblast cultures were established. discrimination of transplanted cells from the host tissue. One attempt to overcome this problem is to mark the After 7 days of cultivation we performed an orthotopic transplantation of 3D myoblast constructs: in nine fe-cells prior to transplantation by stable or transient transfection with marker genes not expressed by the host or-male recipient rats the anterior gracilis muscle was resected microsurgically in part and the 3D cell construct ganism's cells. In case of stable transfection, one has to exclude the possibility of a change in phenotype of vi-was implanted into the created muscle defect. Three animals each were sacrificed on days 2, 25, and 50 after rally transfected cells different from untreated primary cells. On the other hand, the use of transiently transfec-cell transplantation. Implantation sites were excised and processed for anti-desmin immunostaining and Y chro-ted cells faces the problem of dilution of the marker genes with each cell division. Thus, the reliability to de-mosome in situ hybridization to determine the survival, differentiation, and integration of transplanted male my-tect transplanted cells decreases over time.
A lot of research has been done to make syngeneic oblasts ( Fig. 1 ). transplantation possible, which was first achieved in the MATERIALS AND METHODS mouse animal model by identifying a unique sequence Cell Culture on the Y chromosome of the male mouse. For many years now, cross-gender experiments have been carried out in Primary rat myoblasts were obtained from hind limbs this animal model (12, 26) . However, the disadvantage of 3-day-old male syngeneic Wistar-Kyoto rats. Satellite of the mouse as a transplantation model is obvious: cells were dissociated from the minced muscles by dimostly the small size of the animal makes it less feasible gestion with 0.1% collagenase type III (Biochrom, Berfor orthotopic transplantation of whole tissue constructs lin, Germany) for 60 min and 0.25% trypsin [Viralex TM compared with the rat or the rabbit (5). Following the trypsin/EDTA (1×), PAA Laboratories, Linz, Austria] identification of a unique sequence on the Y chromofor 45 min at 37°C and then filtered through a sterile cell some of the rat by Hoebee and Essers (9), the developstrainer (Beckton Dickinson, Franklin Lakes, NJ, USA). ment of tissue and cell transplantation and identification Cells were grown in Dulbecco's modified Eagle's meexperiments within syngeneic rats were rendered possidium (DMEM) containing 1% penicillin/streptomycin ble. Using a probe from the Y chromosome of male rats solution (both from Life Technologies, Paisley, UK) and for in situ hybridization allows detecting transplanted 10% fetal bovine serum (FBS). Each culture was tested male cells in a syngeneic female recipient animal. With for the chromosomal sex of its donor animal by PCR, this technique, nonmanipulated male cells could be culwith primers specific for the rat Y chromosome sequence tured in vitro, transplanted into female hosts without re-91ES8 on extracted genomic DNA, using the DNAeasy jection or immunosuppression, and identified by Y chrokit (Qiagen, Heidelberg, Germany) and common PCR mosome in situ hybridization without the marker gene conditions. Subsequently only Y chromosome-positive being diluted at any time posttransplantation. However, cultures (i.e., deriving from male donor rats) were proonly a few studies have been conducted until now using cessed. Cells were expanded through four passages. 3D this approach. For example, O'Leary and Blakemore demyoblast monocultures were established by resuspending tected male oligodendrocytes after transplantation into 150,000 trypsinized P4 myoblasts in 125 µl growth me- dium supplemented with aprotinin 1000 IU/ml (Trasy-ton X-100 (Sigma-Aldrich, Irvine, UK) 0.25% in PBS for 30 min and then incubated in a humidified chamber lol  Bayer, Leverkusen, Germany) and mixing with 125 µl of fibrinogen (20 mg/ml in isotonic sodium chloride with blocking solution (5% goat serum and 0.1% Triton X-100 in PBS) for 30 min. After washing with PBS, solution, Sigma-Aldrich, Irvine, UK). The myoblasts/ medium/fibrinogen suspension was mixed with 40 µl of sections were incubated with mouse anti-desmin monoclonal antibody (DAKO, Glostrup, Denmark) diluted 1: thrombin (60 IU/ml "Thrombin S" in 40 mM calcium chloride solution, Baxter, Vienna, Austria) and pipetted 100 in blocking solution (2 h at 20°C). Sections were washed with PBS and incubated with FITC-conjugated into a 24-well plate (Costar, Cambridge, MA, USA). The clots were covered with 1 ml growth medium con-anti-mouse IgG for 2 h. Nuclei were stained with propidium iodide (50 µg/ml in PBS) for 20 min. After wash-taining aprotinin 1000 IU/ml and cultured for up to 7 days ( Fig. 2A) .
ing with PBS and mounting with Aquatex Mounting Media (EM Science, Gibbstown, NJ, USA), anti-des-Immunocytochemistry min-stained sections were viewed by fluorescence mi-Clots were placed in potassium hydrogen phosphate croscopy (Zeiss Axioplan, Germany) ( Fig. 2B ). buffer containing 15% sucrose for 20 min. Then clots Transplantation of 3D Myoblast Constructs were embedded in Tissue Freezing Medium  (Leica Instruments, Nussloch, Germany), frozen on a liquid nitro-Nine female Wistar-Kyoto rats were anesthetised with isoflurane and ketamin. Anterior gracilis muscles were gen-cooled plate, and sectioned in a Leica CM3050 cryostat at thickness of 10 µm. Sections were fixed in exposed and partially resected. 3D myoblast constructs were implanted in the created intermuscular space ( 2A), myogenic specificity of the cells was evidenced by positive anti-desmin immunocytochemistry (Fig. 2B ).
Y Chromosome Probe and In Situ Hybridization
Different concentrations of fibrinogen and thrombin and A digoxygenin (DIG)-labeled 300-bp probe of the rat seeding cell density in a 3D matrix were evaluated. We Y chromosome was created using the PCR DIG Probe determined an optimal fibrinogen concentration of 10 Synthesis Kit (Boehringer Mannheim, Germany), with mg/ml per clot, 40 µl of thrombin with 60 IU/ml, yieldthe pUC 18 plasmid containing the rat Y chromosomeing enough stability and providing enough porosity for specific sequence 91ES8 (kind gift from Dr. Barbara cell migration, proliferation, and medium diffusion (Fig.  Hoebee) serving as a template. After confirming the suc-2A). Different antifibrinolytic reagents, like aprotinin cessful DIG labeling PCR by agarose gel electrophoreand ε-amino-capronic acid, were tested and the best resis, the DIG-labeled probe was purified using the PCR sults in terms of prolonged stability of the clot, of minipurification kit (Boehringer Mannheim). Explanted tismum cell toxicity, and of opacity to enable evaluation sue was embedded into tissue freezing medium and cryby phase contrast microscopy were obtained using aprotosections of 10 µm thickness were performed. Sections inin at a final concentration of 500 IU/ml. A high prolifwere dried and Y chromosome in situ hybridization was eration rate of P4 myoblasts within the fibrin matrix could carried out as previously described. In brief, sections were be observed, indicating the feasibility of fibrin gel as 3D pretreated with 30% sodium disulfite and incubated for matrix. Yet there was no evidence of myoblast differen-15 min at 45°C. Then sections were washed with 2× tiation like fusion to myofibers, as expected ( Fig. 2A ). SSC and dehydrated with increasing ethanol concentration (70%, 90%, and 100%). Sections were denatured Transplantation and Anti-Desmin Immunostaining for 20 min at 70°C and cooled down for 2 min in ice-All animals survived the transplantation procedure cold ethanol (70%). After dehydration, 20 µl hybridizaand lived up to the date of explantation without any tion fluid was mixed with 1.2 µl probe and denatured complications. Due to the nonresorbable suture used to for 5 min at 70°C, preannealed for 20 min at 42°C, and close the fascia, cell implantation sites could be identirapidly cooled on ice for 5 min. For hybridization, 24 µl fied in all animals. H&E stainings of en-bloc resected of hybridization/probe mix was pipetted over sections, transplantation sites revealed 3D myoblast constructs resealed with siliconized cover glasses and gum, and fimained in situ 2 days after transplantation, while they nally incubated for 18 h at 37°C. Subsequently, cover were less detectable 25 days after transplantation, beglasses were removed and sections were washed with cause the fibrin matrix was degraded to some dense fiformamide 50%/2× SSC at 45°C, 0.1× SSC at 60°C, bers. The fibrin matrix was dissolved completely 50 days and 4× SSC/Tween at 45°C. Blocking buffer (240 µl after implantation in vivo. The positive anti-desmin per section) was administered and incubated for 30 min.
staining of myoblasts revealed that the cells kept their Sections were covered with 100 µl alkaline phosphatase myogenic phenotype after transplantation ( Fig. 2C-D) . (AP)-conjugated anti-DIG antibody diluted 1:500 in Tris/NaCl washing buffer (containing 0.3% Triton X-Y Chromosome In Situ Hybridization 100) and incubated for 2 h at room temperature. After washing the sections with 4× SSC/Tween and Tris/NaCl Transplanted male myoblasts were identified after 2, washing buffer, sections were embedded in 50 ml AP 25, and 50 days by Y chromosome hybridization. On the substrate for 18 h. Sections were washed with PBS, second day after transplantation, the 3D myoblast conbackground staining with toluidine blue 0.05% was perstructs were still located in situ and the cells were emformed, and sections were mounted with glycerin gelatin bedded within the fibrin matrix; hence, no integration of for microscopic evaluation. All reagents were purchased myoblasts into host muscle tissue was observed ( 3A-B). However, 25 days posttransplantation male mo-Primers used for sex-determining PCR and creating nonuclear myoblasts had assembled at the transition the probe for Y chromosome in situ hybridization were: zone between transplant and host muscle fibers within forward 5′-GCT GGT GAT TTG CAG AGT GA-3′ (corthe remaining fibrin matrix, while part of the transresponding to bp 266-285) and reverse 5′-AAC CCA planted male myoblast population had already fused TGT TTG GTC CAC AT-3′ (corresponding to bp 547with the female host's myofibers ( Fig. 3C-D) . At 50 566), resulting in a defined probe size of 300 bp. days after transplantation the fibrin matrix was no longer detectable and no donor cells identified by Y chromo-ther by trauma or primary muscle disease could be treated by autologous transplantation of engineered skeletal some in situ hybridization presented as single mononuclear myoblasts: all Y chromosome-positive nuclei showed muscle tissue. So far there are two general approaches to engineer artificial skeletal muscle tissue. One method incorporation into female recipient rat muscle fibers ( Fig. 3E-F) , resulting in mosaic multinuclear muscle fi-is to regenerate autologous satellite cells by biopsy, expand and differentiate cells in a 3D defined environment bers in the area of implantation. In the controls where only fibrin matrix had been implanted, no Y chromo-in vitro, and reimplant the neo-tissue after differentiation has taken place. some-positive nuclei were detectable. Findings in the different experimental groups were consistently observed A second approach involves the harvest of satellite cells, expansion of cells in vitro, and reimplantation of histologically in all samples.
donor cells using a transport matrix, which allows differ-DISCUSSION entiation into myotubes in vivo to occur (myoblast trans-Establishing a 3D myoblast culture with a defined fer therapy) (Fig. 1) . 3D cultivation of skeletal muscle matrix composition holds promises for a clinical applicells in fibrin compared with injection of cultivated mycation. Patients with a loss of skeletal muscle tissue eioblasts enables us to prefabricate defined solid con- structs that can be used to refill defects. By using the feasibility for transplantation procedures being shown in different studies, this animal model is obviously prefera-introduced fibrin matrix for 3D cultivation of myoblasts, the complicacy of clinical application related to the use ble (16, 23) . In many studies discrimination between transplanted and recipient cells and tissues was based on of commonly preferred, but possibly hazardous, matrices like Matrigel  could be avoided. However, fibrin has the genetic modification prior to implantation (7, 11, 17) . Because transplantation of genetically manipulated cells many other attributes making it a very attractive candidate for 3D cell cultures: it is biocompatible as well as does not give a realistic insight into donor cell integration like the transplantation of untreated primary cells biodegradable; it is not immunogenic and, in contrast to chemical-engineered biopolymers, there is no risk of provides, as these cells recapitulate morphogenesis more precisely, a superior approach would be indispensable. causing foreign body reaction. Fibrin also has a high affinity to bind to biological surfaces, which renders it
The genetic manipulation of transplanted cells providing a detection system for identification implies the risk of even more feasible for in vivo implantation and integration (4, 14) . Fibrin supports the migration capacity of the altering the physiological and biological behavior of the cells. Therefore, the use of untreated primary cells is cells, allows the diffusion of growth and nutrition factors, and is a nutrient medium itself (2, 6, 19) . Hence, the preferable in cell transplantation research in general and in tissue engineering in particular. Though transient proposed fibrin matrix is a very promising step towards 3D skeletal muscle tissue engineering.
transfection of cells does not comprise these disadvantages to such an extent, this approach faces the problem Many ways to induce differentiation of primary myoblasts include procedures that do not appear suitable of the marker genes being diluted with each cell division. Thus, the possibility to detect transplanted cells for the clinical situation of a patient with no inherited muscle disease but a significant loss of skeletal muscle decreases over time.
To date, the syngeneic rat animal model has not been tissue. For example, transfection of cells with myogenic transcription factors raises concerns about the safety of suitable for cell and tissue transplantation studies due to the lack of a nondilutable marker, preferably on a geno-using these cells in the human (e.g., in terms of tumorgenicity) (13, 25) . Another approach, which has been mic DNA basis. After the identification of the unique Y chromosome sequence 91ES8 by Hoebee and Essers, we successful in inducing differentiation in primary myoblasts, is cocultivation of myoblasts with neuronal slice would suggest the syngeneic rat animal model as favored for studies focusing on transplanting in vitro-engi-cultures (3). Although this model provides a very close insight into development of myogenesis and synapto-neered 3D cell and tissue constructs. The use of Y chromosome in situ hybridization technique in the rat model genesis in vitro, it is obviously restricted to experimental myogenesis studies in vitro or in animal models. Ac-was demonstrated in previous studies. In the central nervous system, O'Leary and Blakemore successfully ap-cording to these circumstances, we have developed a cell transplantation approach of 3D precultivated my-plied the Y chromosome in situ hybridization technique for tracking transplanted oligodendrocytes (20) . Several oblasts that would be accessible via a small muscle biopsy from the patient. Hence, to a certain extent the studies based on the rat Y chromosome in situ hybridization were performed using fluorescent in situ hybridiza-presented procedure would be feasible in a clinical scenario. Taking into consideration that myoblasts need to tion (FISH) (29). Despite the lower sensitivity of AP staining, this appears more conclusive, because it renders be expanded for a successful tissue engineering approach-a fact often neglected when studies on differ-the possibility to evaluate the morphology of the host tissue surrounding the implantation site. Other studies entiating myoblasts for tissue engineering purposes are performed (15)-we cultivated and expanded the pri-focused on the quantification of Y chromosome-positive cells from male donor rats by performing PCR based on mary myoblasts over four passages. Yet 3D cultivation of expanded primary myoblasts within the fibrin matrix the 91ES8 probe (24, 27) . However, these approaches lack the possibility to elucidate morphologically the in-still did not result in dedifferentiation or a fibroblast-rich culture, as revealed by desmin-positive immunostaining tegration process. Therefore, our study combines the advantage of identifying male donor cells in syngeneic (Fig. 2B) .
Because the syngeneic mouse model does not appear female rats based on the 91ES8 sequence with the possibility to localize the cells precisely in relation to the to be suitable for skeletal muscle transplantation studies to further determine the in vivo potential of a 3D my-host tissue by in situ hybridization and AP staining with toluidine blue counterstaining. oblast construct adequately, a syngeneic transplantation model with animals large enough for orthotopic implan-Our results confirm the feasibility of the syngeneic rat transplantation model, because 2 days after transplan-tation and feasible for surgical approaches and procedures is necessary. As most myogenesis-related topics tation the implanted male donor myoblasts could be clearly identified by Y chromosome in situ hybridization (Fig. have been characterized very well in the rat, and the rat's 3A-B). The fibrin matrix was still in place and no evi-we were able to detect transplanted male cells for up to 50 days posttransplantation, revealing male myoblasts dence of inflammation, rejection, or foreign body reaction around the implantation site was visible. This indi-incorporated into female host myofibers. The positive anti-desmin immunostaining confirmed the sustaining cates that prefabricated 3D fibrin constructs may be a promising step towards replacing lost skeletal muscle myogenic specificity of the transplanted cells. Thus, combining 3D cell culturing and rat Y chromosome in tissue in the future. Myoblasts remained in situ even after 25 days and the cells had partially fused with host myo-situ hybridization, major advances can be made in the field of tissue engineering in vitro by mimicking autolo-fibers, indicating the survival and integration of the transplanted cells ( Fig. 3C-D) . Still there were viable Y gous transplantation followed by evaluation of the transplanted cells and tissue fate in vivo. chromosome-positive cells left at the implantation site more than 3 weeks after transplantation, which had not plantation site of the 3D cell construct ( Fig. 3E-F ).
